Genesis HealthCare (GEN) Tops Q1 EPS by 2c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q1 EPS of $0.71, $0.02 better than the analyst estimate of $0.69. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Genesis HealthCare sees Q2 2027 EPS of $0.71-$0.73, versus the consensus of $0.71. Genesis HealthCare sees Q2 2027 revenue of $1.325-1.35 billion, versus the consensus of $1.325 billion.

Genesis HealthCare sees FY2027 EPS of $2.87-$2.97, versus the consensus of $2.90. Genesis HealthCare sees FY2027 revenue of $5.375-5.475 billion, versus the consensus of $5.376 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• ShinyHunters hackers say they stole psychiatric and medical records of DBI staff - Reuters
• Pentagon-Backed Oil Company Is Set to Vie for Chevron's Crown in Venezuela - WSJ